Cargando…
Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection
Cystic lung formation secondary to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was described during coronavirus disease pandemic, but with relatively low prevalence. A rare yet under‐recognized complication is that these cystic areas may progress to bullae, cavities and pn...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344262/ https://www.ncbi.nlm.nih.gov/pubmed/35928243 http://dx.doi.org/10.1002/rcr2.1013 |
_version_ | 1784761182110875648 |
---|---|
author | Abdullah, Hafizah Wong, Yen Shen Ibrahim, Muhammad Amin Natasya Musa, Aisya Jayaraman, Thevaraajan Mohd Zim, Mohd Arif |
author_facet | Abdullah, Hafizah Wong, Yen Shen Ibrahim, Muhammad Amin Natasya Musa, Aisya Jayaraman, Thevaraajan Mohd Zim, Mohd Arif |
author_sort | Abdullah, Hafizah |
collection | PubMed |
description | Cystic lung formation secondary to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was described during coronavirus disease pandemic, but with relatively low prevalence. A rare yet under‐recognized complication is that these cystic areas may progress to bullae, cavities and pneumothorax. We reported two cases of ruptured bullae with pneumothorax following SARS‐CoV‐2 infection. Two patients were discharged following SARS‐CoV‐2 pneumonia, which did not require invasive mechanical ventilation (IMV). However, both patients presented again a month later with shortness of breath. Repeated computed tomography (CT) thorax showed development of bullous lung disease and pneumothorax. The first patient underwent surgical intervention whilst the second patient was treated conservatively. Development of bullous lung disease following SARS‐CoV‐2 infection is rare but may be associated with serious morbidity. Patients whose general condition permits should be offered surgical intervention whilst conservative management is reserved for non‐surgical candidates. |
format | Online Article Text |
id | pubmed-9344262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-93442622022-08-03 Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection Abdullah, Hafizah Wong, Yen Shen Ibrahim, Muhammad Amin Natasya Musa, Aisya Jayaraman, Thevaraajan Mohd Zim, Mohd Arif Respirol Case Rep Case Reports Cystic lung formation secondary to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was described during coronavirus disease pandemic, but with relatively low prevalence. A rare yet under‐recognized complication is that these cystic areas may progress to bullae, cavities and pneumothorax. We reported two cases of ruptured bullae with pneumothorax following SARS‐CoV‐2 infection. Two patients were discharged following SARS‐CoV‐2 pneumonia, which did not require invasive mechanical ventilation (IMV). However, both patients presented again a month later with shortness of breath. Repeated computed tomography (CT) thorax showed development of bullous lung disease and pneumothorax. The first patient underwent surgical intervention whilst the second patient was treated conservatively. Development of bullous lung disease following SARS‐CoV‐2 infection is rare but may be associated with serious morbidity. Patients whose general condition permits should be offered surgical intervention whilst conservative management is reserved for non‐surgical candidates. John Wiley & Sons, Ltd 2022-08-02 /pmc/articles/PMC9344262/ /pubmed/35928243 http://dx.doi.org/10.1002/rcr2.1013 Text en © 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Abdullah, Hafizah Wong, Yen Shen Ibrahim, Muhammad Amin Natasya Musa, Aisya Jayaraman, Thevaraajan Mohd Zim, Mohd Arif Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection |
title | Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection |
title_full | Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection |
title_fullStr | Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection |
title_full_unstemmed | Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection |
title_short | Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection |
title_sort | development of bullous lung disease with pneumothorax following sars‐cov‐2 infection |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344262/ https://www.ncbi.nlm.nih.gov/pubmed/35928243 http://dx.doi.org/10.1002/rcr2.1013 |
work_keys_str_mv | AT abdullahhafizah developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection AT wongyenshen developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection AT ibrahimmuhammadamin developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection AT natasyamusaaisya developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection AT jayaramanthevaraajan developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection AT mohdzimmohdarif developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection |